Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pacer: T3 Stipulation to defer CC Briefing & Hearing Schedule 9-21-12

Thanks for the info update. So the next big date is the 2nd claims construction hearing now scheduled for Nov 30....tick tock

Ron (or anyone else)...any idea what this is?

WHEREAS

, counsel for Technology Properties Limited and Alliacense Limited have a

conflict on November 7, 2012 because of a trial in New Orleans, Louisiana;

Share
New Message
Please login to post a reply